Genus Capital Management Inc. reduced its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 33.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,554 shares of the company’s stock after selling 1,305 shares during the period. Genus Capital Management [...]
Genus Capital Management Inc. Reduces Stake in Merck & Co., Inc. $MRK
